Gut. Published Online First: 11 January 2006. doi:10.1136/gut.2005.082990
Paper |
Cancer risks in LKB1 germline mutation carriers
1 Centre Medico-Chirurgical de Plainpalais, Switzerland
2 Università di Bari, Italy
3 Seoul National University College of Medicine, Korea, Republic of
4 Tokyo Metropolitan Komagome Hospital, Japan
5 Geneva University Hospital, Switzerland
* To whom correspondence should be addressed. E-mail: mehenni{at}cellbio.unige.ch.
Accepted 20 December 2005
Abstract
Background & Aims: Germ-line mutations in the LKB1 gene are known to cause Peutz-Jeghers syndrome (PJS), which is an autosomal dominant disorder characterized by hamartomatous polyposis and muco-cutaneous pigmentation. This syndrome is associated with an increased risk of malignancies in different organs but there is a lack of data on cancer range and risk in LKB1 germ-line mutation carriers.
Patients & Methods: The cumulative incidence of cancer in 149 PJS patients with germ-line mutation(s) in LKB1 was estimated with Kaplan-Meier time-to-cancer onset analyses and compared between relevant subgroups with log rank tests.
Results: 32 cancers were found in the LKB1 mutation carriers. Overall cancer risks at ages 30, 40, 50, 60, and 70 years, respectively, were 6%, 18%, 31%, 41%, and 67%. There were similar overall cancer risks between male and female carriers. However, there were overall cancer risk differences for exon 6 mutation carriers vs. non-exon 6 mutation carriers (log rank p = 0.022 overall, 0.56 in males, 0.0000084 in females). Most (22/32) of the cancers occurred in the gastrointestinal tract, and the overall gastrointestinal cancer risks at ages 40, 50, 60, and 70 years, respectively, were 12%, 24%, 34%, and 63%. In females the risks for developing gynecologic cancer at ages 40, and 50 years, respectively, were 13%, and 18%.
Conclusions: Mutations in exon 6 of LKB1 are associated with a higher cancer risk than mutations within other regions of the gene. Moreover, this study provides age-related cumulative risks of developing cancer in LKB1 mutation carriers that should be useful for developing a tailor-made cancer surveillance protocol for PJS patients.
Keywords: Exon specific risk, LKB1 gene mutations, Peutz-Jeghers syndrome, cumulative cancer risk, surveillance
Relevant Article
- Digest
- Robin Spiller and Alastair Watson
Gut 2006 55: 905.[Extract] [Full Text] [PDF]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
